Established in 2013, before becoming a designated Major Centre in 2015, the CRUK Manchester Centre is a translational research centre that unites basic, translational and clinical research in order to deliver cancer precision for all. We prioritise our research across five distinct research themes across seven key disease sites. The CRUK Manchester Centre has been recognised as a ‘Major Centre’ and is led by Professor Robert Bristow. It helps to support activities in three core areas:
- Accelerating translation of lab-based discoveries into the clinic
- Improving access and efficiency of treatment for patients with cancer
- Training the next-generation of world-leading cancer scientists
The Cancer Research UK Manchester Centre has a unique opportunity to implement a precision medicine approach to treatment across the full spectrum of cancer research, from the lab to treatment. Research we undertake will go on to dramatically improve patient outcomes, now and for years in the future.
Professor Robert Bristow
Director, CRUK Manchester Centre
We have a vision to deliver Cancer Precision for All: Uniting translational and clinical excellence to deliver a cancer free future.
To achieve our vision, the Centre benefits from the strong partnership and critical mass of cancer research activities in Manchester including at The University of Manchester, Cancer Research UK and The Christie NHS Foundation Trust as well as the other centres, and facilities across Manchester. We recognise the strength and benefit of working collaboratively with our partners and the potential this has to dramatically improve the treatment for cancer patients.
Our researchers have access to state-of-the-art facilities at The University of Manchester, including the Oglesby Cancer Research Building as well as the core-funded Cancer Research UK Manchester Institute (CRUK MI), and unparalleled access to world-leading cancer treatment facilities at The Christie and other NHS Facilities across Manchester.
We are investing in the advanced infrastructure to support our ambition. This will support groundbreaking laboratory, translational and clinical research across five key themes:
- Cancer Biomarkers
- Cancer Early Detection
- Experimental Cancer Medicine
- Integrative Pathology
- Radiotherapy BioAdaption
Research is prioritised across seven key disease sites: breast, gynaecological, haematological, hepato-pancreato-billiary, lung, melanoma and prostate cancers. Areas of strategic growth for the Centre include central nervous system and paediatric oncology and immuno-oncology. Underpinning all of our research innovations is digital technology, spearheaded by the Digital Cancer Centre, which cross cuts all of our research themes and helps to deliver technological innovations in artificial intelligence, routine monitoring of patient data, big data and machine learning.
Together with colleagues across the Cancer Research UK network of Centres, and collaborators from within the UK and further afield, we can work to achieve personalised medicine for all cancer patients worldwide.
We cannot achieve our vision alone. That's why collaboration lies at the heart of the Centre.
Access a library of resources about the CRUK Manchester Centre, including brochures, newsletters and information sheets.
Discover more about how the Centre is governed, from Theme Leads to the International Advisory Board.
Infrastructure and Facilities
Find out about some of the cutting-edge laboratory and clinical equipment available to researchers in Manchester.